Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-01 Sale |
2024-08-02 4:05 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
4,149 | $0.35 | $1,452 | 172,436 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-06 4:15 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
3,936 | $0.75 | $2,952 | 176,585 (Direct) |
View |
| 2024-04-05 Sale |
2024-04-09 4:22 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana CHIEF MEDICAL OFFICER |
2,753 | $0.83 | $2,285 | 53,365 (Direct) |
View |
| 2024-04-05 Sale |
2024-04-09 4:21 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. |
2,753 | $0.83 | $2,285 | 88,247 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 4:24 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. |
3,293 | $0.89 | $2,931 | 91,000 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 4:19 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
5,834 | $0.89 | $5,192 | 180,521 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 4:13 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana CHIEF MEDICAL OFFICER |
3,293 | $0.89 | $2,931 | 56,118 (Direct) |
View |
| 2023-02-08 Sale |
2024-02-12 5:16 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. |
7,770 | $0.53 | $4,118 | 94,293 (Direct) |
View |
| 2023-02-08 Sale |
2024-02-12 5:15 pm |
Cara Therapeutics Inc. | CARA | Maynard Ryan D CHIEF FINANCIAL OFFICER |
5,488 | $0.53 | $2,909 | 8,012 (Direct) |
View |
| 2023-02-08 Sale |
2024-02-12 5:13 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana CHIEF MEDICAL OFFICER |
7,770 | $0.53 | $4,118 | 59,411 (Direct) |
View |
| 2024-02-08 Sale |
2024-02-12 5:10 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
35,575 | $0.53 | $18,855 | 186,355 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-05 4:26 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
4,981 | $0.55 | $2,740 | 221,930 (Direct) |
View |
| 2023-11-02 Sale |
2023-11-03 4:37 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
3,796 | $1.22 | $4,631 | 164,411 (Direct) |
View |
| 2023-08-03 Sale |
2023-08-04 5:21 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
4,307 | $3.07 | $13,222 | 168,207 (Direct) |
View |
| 2023-06-23 Sale |
2023-06-27 4:09 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
2,483 | $3.51 | $8,715 | 88,563 (Direct) |
View |
| 2023-06-23 Sale |
2023-06-27 4:08 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
2,993 | $3.51 | $10,505 | 153,747 (Direct) |
View |
| 2023-06-23 Sale |
2023-06-27 4:07 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
2,723 | $3.51 | $9,558 | 53,681 (Direct) |
View |
| 2023-05-05 Sale |
2023-05-09 4:22 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
3,869 | $4.4 | $17,024 | 172,514 (Direct) |
View |
| 2023-04-04 Sale |
2023-04-06 5:14 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
2,481 | $4.91 | $12,182 | 91,046 (Direct) |
View |
| 2023-04-04 Sale |
2023-04-06 5:13 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
2,481 | $4.91 | $12,182 | 56,404 (Direct) |
View |
| 2023-04-04 Sale |
2023-04-06 5:12 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
2,733 | $4.91 | $13,419 | 156,740 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-07 4:47 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
5,987 | $9.71 | $58,134 | 176,383 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-07 4:46 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
6,802 | $9.71 | $66,047 | 159,473 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-04 Option Award |
2024-06-06 4:28 pm |
N/A 2034-06-04 |
Cara Therapeutics Inc. | CARA | Boudreau Helen M Director |
345,647 | $0 | 345,647 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:26 pm |
N/A 2034-06-04 |
Cara Therapeutics Inc. | CARA | von Moltke Lisa Director |
345,647 | $0 | 378,009 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:25 pm |
N/A 2034-06-04 |
Cara Therapeutics Inc. | CARA | Ives Jeffrey L. Director |
345,647 | $0 | 393,485 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:24 pm |
N/A 2034-06-04 |
Cara Therapeutics Inc. | CARA | Shiff Susan Ph.D. Director |
345,647 | $0 | 397,085 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:22 pm |
N/A 2034-06-04 |
Cara Therapeutics Inc. | CARA | VOGELBAUM MARTIN Director |
691,295 | $0 | 801,007 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:34 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. |
13,500 | $0 | 102,063 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:32 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Maynard Ryan D CHIEF FINANCIAL OFFICER |
13,500 | $0 | 13,500 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:30 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Goncalves Joana CHIEF MEDICAL OFFICER |
13,500 | $0 | 67,181 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:28 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. CHIEF SCIENTIFIC OFF,SVP-R&D |
13,500 | $0 | 167,247 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:26 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO |
62,500 | $0 | 221,930 (Direct) |
View |
| 2023-08-02 Option Award |
2023-08-04 5:20 pm |
N/A 2033-08-02 |
Cara Therapeutics Inc. | CARA | Boudreau Helen M Director |
155,747 | $0 | 155,747 (Direct) |
View |
Ownership |
2023-07-25 4:13 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | CSL LTD 10% Owner |
0 | $0 | 7,396,770 (Indirect) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:36 pm |
N/A 2033-06-01 |
Cara Therapeutics Inc. | CARA | von Moltke Lisa Director |
77,323 | $0 | 77,323 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:34 pm |
N/A 2033-06-01 |
Cara Therapeutics Inc. | CARA | Shiff Susan Ph.D. Director |
77,323 | $0 | 96,399 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:33 pm |
N/A 2033-06-01 |
Cara Therapeutics Inc. | CARA | Ives Jeffrey L. Director |
77,323 | $0 | 92,799 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:31 pm |
N/A 2033-06-01 |
Cara Therapeutics Inc. | CARA | BAINS HARRISON M JR Director |
77,323 | $0 | 102,399 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:29 pm |
N/A 2033-06-01 |
Cara Therapeutics Inc. | CARA | VOGELBAUM MARTIN Director |
154,647 | $0 | 199,635 (Direct) |
View |